Last reviewed · How we verify

NCT03797118

One-Dimensional Mathematical Model-Based Automated Assessment of Fractional Flow Reserve

Completed NA Last updated 18 May 2020
What this trial tests

NA trial testing FFR in Coronary Artery Disease in 31 participants. Completed in 5 July 2019.

Timeline
5 April 2017
Primary endpoint
5 June 2019
5 July 2019

Quick facts

Lead sponsorI.M. Sechenov First Moscow State Medical University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposediagnostic
Enrollment31
Start date5 April 2017
Primary completion5 June 2019
Estimated completion5 July 2019
Sites1 location across Russia

Drugs / interventions tested

Conditions studied

Sponsor

I.M. Sechenov First Moscow State Medical University

Who can join

Adults 18 to 85, any sex, with Coronary Artery Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study evaluates the diagnostic efficiency of an automated method of noninvasive assessment of the fractional reserve of coronary blood flow. Fractional flow reserve is estimated with a one-dimensional mathematical model constructed by means of an automated algorithm. Noninvasive method values are thereafter compared with invasive method values.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Noninvasive Assessment of the Fractional Flow Reserve with the CT FFRc 1D Method: Final Results of a Pilot Study.
    Gognieva D, Mitina Y, Gamilov T, Pryamonosov R, et al · · 2021 · cited 3× · PMID 33598381 · DOI 10.5334/gh.837

Verify or expand the search:

Other trials of FFR

Trials testing the same drug.

Other recruiting trials for Coronary Artery Disease

Currently open trials in the same condition.

Other I.M. Sechenov First Moscow State Medical University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03797118.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing